UK Markets close in 5 hrs 39 mins

Formycon AG (0W4N.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
79.50+0.07 (+0.09%)
As of 08:02AM GMT. Market open.
Full screen
Previous close79.43
Open79.50
Bid0.00 x N/A
Ask0.00 x N/A
Day's range79.50 - 79.50
52-week range79.50 - 79.50
Volume6
Avg. volumeN/A
Market cap669.015M
Beta (5Y monthly)1.07
PE ratio (TTM)N/A
EPS (TTM)-0.30
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study

    EQS-News: Formycon AG / Key word(s): Study results/StudyAflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study 06.02.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // February 6, 2023Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study MAGELLAN-AMD study demonstrates the comparable efficacy of FYB203 to the refer

  • EQS Group

    Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)

    EQS-News: Formycon AG / Key word(s): Agreement/AllianceFormycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab) 02.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release February 2, 2023Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)Munich – Formycon AG (ISIN: DE000A1EWVY8/ WKN:

  • EQS Group

    Formycon AG announces result of private placement and sets placement price for the new shares from the capital increase

    Formycon AG / Key word(s): Capital Increase/Corporate ActionFormycon AG announces result of private placement and sets placement price for the new shares from the capital increase02-Feb-2023 / 07:30 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, I